EB
Entact Bio, Inc.
SEC filingBiotechnology · Watertown, MA
Amount raised$10Msold at filing
Total offering$10M
Investors in the raise7count reported to the SEC
FiledJun 3, 2026first sale Jan 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrew SinclairDirector
Anna FrenchDirector
Pini OrbachDirector
Victoria RichonExecutive Officer, Director, Promoter
Richard GasterDirector
Owen SmithDirector
Executive officers, directors and promoters as listed on the Form D.